Salgymeda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 503,609 | 615,208 | 652,283 | 686,034 | 672,914 | 743,749 | 934,723 | 951,144 |
| Profit before tax | 38,482 | 67,270 | 44,268 | -52,875 | 47,530 | -18,310 | 41,449 | -13,029 |
| Net profit | 36,613 | 64,799 | 42,970 | -52,875 | 47,129 | -18,310 | 39,437 | -13,029 |
| Equity | 117,307 | 182,106 | 258,165 | 87,642 | 101,682 | 83,372 | 122,809 | 109,780 |
| Liabilities | 234,539 | 164,757 | 105,378 | 79,981 | 34,711 | 23,422 | 21,560 | 25,054 |
| Non-current assets | 268,254 | 220,803 | 255,627 | 34,997 | 22,302 | 20,051 | 15,142 | 14,177 |
| Current assets | 83,592 | 125,772 | 107,066 | 132,057 | 114,062 | 86,415 | 128,809 | 120,187 |
| Total assets | 351,846 | 346,575 | 362,693 | 167,054 | 136,364 | 106,466 | 143,951 | 134,364 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 108,928 | 126,296 | 146,746 |
| Social insurance contributions | - | - | - | - | - | 126,694 | 154,137 | 169,100 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +16.7% | +22.2% | +6.0% | +5.2% | -1.9% | +10.5% | +25.7% | +1.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 10.4% | 18.7% | 11.8% | -31.7% | 34.6% | -17.2% | 27.4% | -9.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 31.2% | 35.6% | 16.6% | -60.3% | 46.3% | -22.0% | 32.1% | -11.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.3% | 10.5% | 6.6% | -7.7% | 7.0% | -2.5% | 4.2% | -1.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.6% | 10.9% | 6.8% | -7.7% | 7.1% | -2.5% | 4.4% | -1.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.0 | 0.9 | 0.4 | 0.9 | 0.3 | 0.3 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 17,217 | 20,394 | 20,598 | 22,741 | 22,307 | 26,096 | 30,563 | 34,071 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Salgymeda - Social security debts
The company had no debts to Sodra
Salgymeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-03-09 | 2025-03-12 | 713.5 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Salgymeda, UAB (company code 300119071) is a Private Limited Liability Company engaged in general medical practice activities. In the latest financial year, 2025, the company generated revenue of €951.1K, up 1.8% year on year and 27.9% over two years. Profitability weakened after a strong 2024 result: net profit was -€13.0K in 2025, compared with €39.4K in 2024 and -€18.3K in 2023. This resulted in a negative profit margin of -1.4% in 2025, following 4.2% in 2024 and -2.5% in 2023. The balance sheet remained modest in size, with total assets of €134.4K, equity of €109.8K and liabilities of €25.1K at year-end 2025. Equity represented 81.7% of assets, while debt-to-equity stood at 0.23. Asset turnover was 7.08x, indicating efficient use of assets in generating revenue. Return on equity was -11.9% and return on assets was -9.7% in 2025. Revenue per employee amounted to €35.2K, while profit per employee was -€483.